FDA Media Alert Detail

Drug Recall

FDA Drug Recall: Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457...

  • U.S. Food and Drug Administration
  • September 2, 2026
  • ID: D-0785-2026

Drug Enforcement Report Details

Recall NumberD-0785-2026
Recalling FirmACCORD HEALTHCARE, INC.
ClassificationClass II
Voluntary / MandatedVoluntary: Firm initiated
Distribution PatternNationwide within the United States
StatusOngoing
Product Description

Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-count bottles (NDC 16729-457-17), Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India.

Reason for Recall

Subpotent Drug

Code Information

a) Lot # D2402430, D2402431, Exp Date: 10/31/2026. b) Lot #: D2402432, Exp. Date 10/31/2026; D2500180, Exp. Date 12/31/2026.


Content syndicated from the U.S. Food and Drug Administration (FDA) drug enforcement reports database.